Skip to main content
Premium Trial:

Request an Annual Quote

US Genomics Pens MicroRNAs Agreement With Lahey Clinic to Study Urologic Cancer

NEW YORK (GenomeWeb News) — US Genomics has signed an agreement with the Lahey Clinic to look at microRNAs and the development of urologic cancers, the company said today.
 
The company said that the Lahey Clinic will use US Genomics’ Trilogy 2020 molecule detection platform and its Direct miRNA assay to “develop more accurate prognoses” for patients suffering from bladder cancer and prostate cancer.
 
Lahey Clinic urologist John Libertino adds that this agreement should help develop diagnostics used for “several major urologic cancers.”
 
Financial terms of the agreement were not disclosed.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.